MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $151K of MaxCyte, Inc.
Sold$150,852
$5.03Price
30,000Shares
−8%Stake
What MXCT did after the filing
- The stock from Wed, Jul 12 close, $5.00
- −25.6%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Aug 23 close.
Traded Mon, Jul 10. Filed Wed, Jul 12, 2:06 PM ET, during the session. Returns use the Jul 12 close and the Aug 23 close. Not investment advice.